Trials / Completed
CompletedNCT00944567
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (actual)
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A non-profit study designed with the aim of analysing the phenotype and molecular characteristics (central review) and evaluating prospectively the role of PET-scans in the management of primary mediastinal lymphoma treated with conventional approaches.
Conditions
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2011-05-01
- Completion
- 2017-02-27
- First posted
- 2009-07-23
- Last updated
- 2017-08-15
Locations
20 sites across 4 countries: Italy, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00944567. Inclusion in this directory is not an endorsement.